Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2546 USD | -27.26% |
|
-62.16% | -65.73% |
Jun. 13 | Needham Downgrades Cara Therapeutics to Hold From Buy | MT |
Jun. 13 | HC Wainwright Downgrades Cara Therapeutics to Neutral From Buy | MT |
Financials (USD)
Sales 2024 * | 6.41M | Sales 2025 * | 7.39M | Capitalization | 13.92M |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -44M | EV / Sales 2024 * | 5.52 x |
Net Debt 2024 * | 21.5M | Net Debt 2025 * | 78.9M | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
-0.2
x | P/E ratio 2025 * |
-0.35
x | Employees | 55 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.75% |
Latest transcript on Cara Therapeutics, Inc.
1 day | -27.26% | ||
1 week | -62.16% | ||
Current month | -60.79% | ||
1 month | -66.06% | ||
3 months | -71.01% | ||
6 months | -79.30% | ||
Current year | -65.73% |
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
![Extreme 0.24](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 18-08-05 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 22-09-11 |
Scott Terrillion
CMP | Compliance Officer | 61 | 16-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 10-06-30 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 14-07-15 |
Helen Boudreau
BRD | Director/Board Member | 58 | 23-08-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.20% | 30 M€ | +4.45% | - | |
1.29% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-17 | 0.2546 | -27.26% | 4,242,192 |
24-06-14 | 0.35 | -21.10% | 2,141,418 |
24-06-13 | 0.4436 | -34.72% | 3,228,833 |
24-06-12 | 0.6795 | +2.50% | 492,216 |
24-06-11 | 0.6629 | -1.47% | 217,756 |
Delayed Quote Nasdaq, June 17, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.73% | 13.92M | |
+2.52% | 92.1B | |
-3.16% | 37.92B | |
-12.49% | 32.97B | |
+73.70% | 27.92B | |
-11.82% | 16.14B | |
-0.16% | 14.1B | |
-11.18% | 11.66B | |
+171.57% | 10.29B | |
-50.45% | 9.99B |
- Stock Market
- Equities
- CARA Stock